Sharon Mates

Chairman & CEO, Intra-Cellular Therapies Inc.

Sharon-MatesDr. Mates is the Chairman and Chief Executive Officer of Intra-Cellular Therapies, Inc., a company focusing on the development of new drugs for psychiatric and neurodegenerative diseases, including schizophrenia, depression, bi-polar disorder, autism, Parkinson’s disease and Alzheimer’s disease. Dr. Mates has over 24 years of experience in the biotechnology industry ranging from founding several start-up ventures to leading a publicly traded company.  From 1989 – 1998 Dr. Mates was the President of North American Vaccine and its predecessor companies. From 1998 to 2002 Dr. Mates was involved in founding several biotech companies. In 2002, along with Dr. Paul Greengard, Moshe Alafi and Dr. Allen Fienberg, Dr. Mates founded Intra-Cellular Therapies Inc. Dr. Mates recently completed a two-year chairmanship of the Board of the New York Biotechnology Association and serves on the NYBA Board, along with other board memberships. Prior to her role in the biotechnology industry, Dr. Mates spent several years as a research analyst and an investment banker.